A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects

By Watabe Mitsuo   Cheng Yi-Fang   Nilsson Dag   Itoh Yohji   Kumagai Yuji  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1849-1857

Informa Healthcare

Access to resources Recommend Favorite

Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics

By Shrewsbury Stephen B.   Kori Shashidhar H.   David Miller S.   Pedinoff Andrew   Weinstein Steven  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite

Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1058-1068

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1048-1057

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures

By  

EPILEPSIA, Vol. 56, Iss. 12, 2015-12 ,pp. : 1890-1898

John Wiley & Sons Inc

Access to resources Recommend Favorite